Systemic Injection of CK2.3, a Novel Peptide Acting Downstream of Bone Morphogenetic Protein Receptor BMPRIa, Leads to Increased Trabecular Bone Mass

Publisher： John Wiley & Sons Inc

E-ISSN： 1554-527x|33|2|208-215

ISSN： 0736-0266

Source： JOURNAL OF ORTHOPAEDIC RESEARCH, Vol.33, Iss.2, 2015-02, pp. : 208-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bone morphogenetic protein signal transduction in bone

By ten Dijke P.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-07 ,pp. : 7-11

Informa Healthcare

Access to resources Recommend Favorite

Bone morphogenetic proteins in orthopaedic trauma: recent clinical findings with human bone morphogenetic protein-2 (rhBMP-2)

By Patel A. D.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-07 ,pp. : 1-5

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA-153 suppresses the osteogenic differentiation of human mesenchymal stem cells by targeting bone morphogenetic protein receptor type II

By      

International Journal of Molecular Medicine, Vol. 36, Iss. 3, 2015-01 ,pp. : 760-766

Spandidos Publications

Access to resources Recommend Favorite

Recent developments in the use of bone morphogenetic protein in orthopaedic trauma surgery

By Nordsletten L.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-07 ,pp. : 13-17

Informa Healthcare

Access to resources Recommend Favorite

Functions of the bone morphogenetic protein signaling pathway through microRNAs (Review)

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 3, 2015-03 ,pp. : 563-568

Spandidos Publications

Access to resources Recommend Favorite